Contemporary Distribution of High-Grade Prostate Cancer in the Circumstances of Opportunistic Testing

1. Arnold M, Karim-Kos HE, Coebergh JW, Byrnes G, Antilla A, Ferlay J, et al. (2015). Recent trends in incidence of five common cancers in 26 European countries since 1988: analysis of the European Cancer Observatory. Eur J Cancer 51(9):1164-87. doi: 10.1016/j.ejca.2013.09.002.24120180Open DOISearch in Google Scholar

2. Hoffman RM, Meisner AL, Arap W, Barry M, Shah SK, Zeliadt SB, et al. (2016). Trends in United States Prostate Cancer Incidence Rates by Age and Stage, 1995-2012. Cancer Epidemiol Biomarkers Prev. 25(2):259-63. doi: 10.1158/1055-9965.EPI-15-0723.26646364Open DOISearch in Google Scholar

3. Shao YH, Demissie K, Shih W, Mehta AR, Stein MN, Roberts CB, et al. (2009). Contemporary risk profile of prostate cancer in the United States. J Natl Cancer Inst. 101(18):1280-3. doi: 10.1093/jnci/djp262.274472919713548Open DOISearch in Google Scholar

4. van Poppel H (2014). Locally advanced and high risk prostate cancer: The best indication for initial radical prostatectomy? Asian J Urol. 1(1):40-45. doi: 10.1016/j.ajur.2014.09.009.583288329511636Open DOISearch in Google Scholar

5. Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, et al. (eds) (2018). SEER Cancer Statistics Review, 1975-2015, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2015/. Accessed April 30, 2018.Search in Google Scholar

6. Institut za javno zdravlje Srbije „Dr Milan Jovanović Batut“. Incidencija i mortalitet od raka u centralnoj Srbiji, 1999-2008. [cited 2016 Apr 30]. Available from: http://www.batut.org.rs/.Search in Google Scholar

7. Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL; ISUP Grading Committee (2005). The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 29(9):1228-42. PubMed PMID: 16096414.Search in Google Scholar

8. Brawley OW (2012). Trends in prostate cancer in the United States. J Natl Cancer Inst Monogr. 2012(45):152-6. doi: 10.1093/jncimonographs/lgs035.354088123271766Open DOISearch in Google Scholar

9. Pepe P, Pennisi M (2015). Gleason score stratification according to age at diagnosis in 1028 men. Contemp Oncol (Pozn). 19(6):471-3. doi: 10.5114/wo.2015.56654.473145426843845Open DOISearch in Google Scholar

10. Muralidhar V, Ziehr DR, Mahal BA, Chen YW, Nezolosky MD, Viswanathan VB, et al. (2015). Association Between Older Age and Increasing Gleason Score. Clin Genitourin Cancer. 13(6):525-30.e1-3. doi: 10.1016/j.clgc.2015.05.007.26119229Open DOISearch in Google Scholar

11. Ji G, Huang C, Song G, Xiong G, Fang D, Wang H, et al. (2017). Are the Pathological Characteristics of Prostate Cancer More Aggressive or More Indolent Depending upon the Patient Age? Biomed Res Int. 2017:1438027. doi: 10.1155/2017/1438027.531862028265568Open DOISearch in Google Scholar

12. Epstein JI, Walsh PC, Carter HB (2001). Dedifferentiation of prostate cancer grade with time in men followed expectantly for stage T1c disease. J Urol. 166(5):1688-91. PubMed PMID: 11586203.Search in Google Scholar

13. Alibhai SM, Krahn MD, Fleshner NE, Cohen MM, Tomlinson GA, Naglie G (2004). The association between patient age and prostate cancer stage and grade at diagnosis. BJU Int. 94(3):303-6. PubMed PMID: 15291856.Search in Google Scholar

14. Pierorazio PM, Walsh PC, Partin AW, Epstein JI (2013). Prognostic Gleason grade grouping: data based on the modified Gleason scoring system. BJU Int. 111:753–60. doi: 10.1111/j.1464-410X.2012.11611.x.397814523464824Open DOISearch in Google Scholar

15. Epstein JI, Zelefsky MJ, Sjoberg DD, Nelson JB, Egevad L, Magi-Galluzzi C, et al. (2016). A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score. Eur Urol. 69(3):428-35. doi: 10.1016/j.eururo.2015.06.046.500299226166626Open DOISearch in Google Scholar

16. Benson MC, Whang IS, Pantuck A, Ring K, Kaplan SA, Olsson CA, et al. (1992). Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol.147(3 Pt 2):815-6. PubMed PMID: 1371554.Search in Google Scholar

17. Kulkarni GS, Al-Azab R, Lockwood G, Toi A, Evans A, Trachtenberg J, et al. (2006). Evidence for a biopsy derived grade artifact among larger prostate glands. J Urol. 175:505-9. PubMed PMID: 16406982.Search in Google Scholar

18. Yilmaz H, Ustuner M, Ciftci S, Yavuz U, Ozkan TA, Dillioglugil O (2014). Prostate volume predicts high grade prostate cancer both in digital rectal examination negative (ct1c) and positive (≥ct2) patients. Int Braz J Urol. 40(5):613-9. doi: 10.1590/S1677-5538.Open DOISearch in Google Scholar

19. Ngo TC, Conti SL, Shinghal R, Presti JC Jr (2012). Prostate size does not predict high grade cancer. J Urol. 187:477-80. doi: 10.1016/j.juro.2011.10.042.22177152Open DOISearch in Google Scholar

20. Stackhouse DA, Sun L, Schroeck FR, Jayachandran J, Caire AA, Acholo CO, et al. (2009). Factors predicting prostatic biopsy Gleason sum under grading. J Urol. 182(1):118-22. doi: 10.1016/j.juro.2009.02.127.19447436Open DOISearch in Google Scholar

21. Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, et al. (2017). EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 71(4):618-629. doi: 10.1016/j.eururo.2016.08.003.27568654Open DOISearch in Google Scholar

22. Heidenreich A, Abrahamsson PA, Artibani W, Catto J, Montorsi F, Van Poppel H, et al. (2013). Early detection of prostate cancer: European Association of Urology recommendation. Eur Urol. 64(3):347-54. doi: 10.1016/j.eururo.2013.06.051.23856038Open DOISearch in Google Scholar

23. Reese AC, Wessel SR, Fisher SG, Mydlo JH (2016). Evidence of prostate cancer “reverse stage migration” toward more advanced disease at diagnosis: Data from the Pennsylvania Cancer Registry. Urol Oncol. 34(8):335.e21-8. doi: 10.1016/j.urolonc.2016.03.014.27108226Open DOISearch in Google Scholar

24. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. ERSPC Investigators (2012). Prostate-cancer mortality at 11 years of follow-up. N Engl J Med. 366(11):981-90. doi: 10.1056/NEJMoa1113135.602758522417251Open DOISearch in Google Scholar

25. Jani AB, Master VA, Rossi PJ, Liauw SL, Johnstone PA (2007). Grade migration in prostate cancer: an analysis using the Surveillance, Epidemiology, and End Results registry. Prostate Cancer Prostatic Dis. 10(4):347-51. PubMed PMID: 17505529.Search in Google Scholar

26. Siddiqui MM, Rais-Bahrami S, Turkbey B, George AK, Rothwax J, Shakir N, et al. (2015). Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA. 313(4):390-7. doi: 10.1001/jama.2014.17942.457257525626035Open DOISearch in Google Scholar